OMP-52M51 Uses, Dosage, Side Effects and more
OMP-52M51 has been used in trials studying the treatment of Adenoid Cystic Carcinoma, Relapsed or Refractory Solid Tumors, and Relapsed or Refractory Lymphoid Malignancies.
| Trade Name | OMP-52M51 |
| Generic | Brontictuzumab |
| Brontictuzumab Other Names | Brontictuzumab, OMP-52M51 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
